Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Respiratory Investigation|July 15, 2020
Effect of pulmonary rehabilitation programs including lower limb endurance training on dyspnea in stable COPD: A systematic review and meta-analysisYuji Higashimoto, Morihide Ando, Akiko Sano, et al.
Canadian Respiratory Journal|July 23, 2016
Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung DiseaseOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.
Respiratory Investigation|January 13, 2018
Physical activity in daily life in patients with idiopathic pulmonary fibrosisOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 18, 2006
[Use of transport medium in sputum bacterial culture examination of lower airway infection]Masato Muraki, Sayako Kitaguchi, Hideo Ichihashi, et al.
Biochemistry and Biophysics Reports|September 6, 2021
The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophagesTakashi Matsuhira, Osamu Nishiyama, Yuji Tabata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2016
Characteristics of phenotypes of elderly patients with asthmaHiroyuki Sano, Takashi Iwanaga, Osamu Nishiyama, et al.
International Immunopharmacology|November 16, 2002
Role of muscarinic acetylcholine receptors in a guinea pig model of asthmaYuji Tohda, Ryuta Haraguchi, Mari Itoh, et al.
Internal Medicine (Tokyo, Japan)|December 3, 2014
Cavitary pulmonary cryptococcosis with an Aspergillus fungus ballYasushi Makino, Osamu Nishiyama, Hiroyuki Sano, et al.
BMC Pulmonary Medicine|January 14, 2021
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary diseaseMasato Muraki, Yuki Kunita, Ken Shirahase, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 9, 2021
Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in JapanYuji Tohda, Hisako Matsumoto, Masanori Miyata, et al.
Pageof 14